Viemed Healthcare, Inc.
Viemed Healthcare, Inc. (VMD) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
vmd · stock forecast · 1 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 1 Wall Street analysts in the past 3 months
Buy
1 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $9.92
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $9.99 | ↑ 0.73% |
1-day model range: $9.93–$10.05. Peak: $10.05 (+0.73%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $10 | +3.9% |
| 2028 | $11 | +6.1% |
| 2029 | $11 | +7.4% |
| 2030 | $11 | +8.1% |
| 2031 | — | +8.5% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · VMD · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2021-11-03 | RBC Capital | Maintains | Outperform→Outperform |
| 2021-03-05 | RBC Capital | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Viemed Healthcare, Inc. (VMD) stock. Of the recent 2 rating actions, 0 were upgrades and 0 were downgrades. 1 analysts currently cover VMD.
Analyst Recommendation Trends
VMD analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$224M
↓ 29.5% YoY
Revenue Next Year
$272M
↑ 21.5% YoY
EPS This Year
$0.28
EPS Next Year
$0.40
↑ 41.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast VMD EPS of $0.28 for the current fiscal year, based on estimates from 1 analysts. The VMD revenue forecast is $224M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The VMD stock forecast is supported by two independent data sources: analyst consensus ratings from 1 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus VMD price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The VMD short-term stock prediction for tomorrow is $9.99 (+0.73%). The VMD stock price prediction for 2027 estimates an average of $10. The VMD stock prediction for 2030 projects a range of $10–$11.
Viemed Healthcare, Inc. trades on NASDAQ under the ticker VMD. The VMD stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
VMD forecast · 8 questionsAccording to 1 Wall Street analysts, the average 12-month VMD price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $9.92.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.